Literature DB >> 10481313

Transfer of chloramphenicol-resistant mitochondrial DNA into the chimeric mouse.

S E Levy1, K G Waymire, Y L Kim, G R MacGregor, D C Wallace.   

Abstract

The mitochondrial DNA (mtDNA) chloramphenicol (CAP)-resistance (CAPR) mutation has been introduced into the tissues of adult mice via female embryonic stem (ES) cells. The endogenous CAP-sensitive (CAPS) mtDNAs were eliminated by treatment of the ES cells with the lipophilic dye Rhodamine-6-G (R-6-G). The ES cells were then fused to enucleated cell cytoplasts prepared from the CAPR mouse cell line 501-1. This procedure converted the ES cell mtDNA from 100% wild-type to 100% mutant. The CAPR ES cells were then injected into blastocysts and viable chimeric mice were isolated. Molecular testing for the CAPR mutant mtDNAs revealed that the percentage of mutant mtDNAs varied from zero to approximately 50% in the tissues analyzed. The highest percentage of mutant mtDNA was found in the kidney in three of the chimeric animals tested. These data suggest that, with improved efficiency, it may be possible to transmit exogenous mtDNA mutants through the mouse germ-line.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10481313      PMCID: PMC3049807          DOI: 10.1023/a:1008967412955

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  28 in total

1.  Production of transmitochondrial mouse cell lines by cybrid rescue of rhodamine-6G pre-treated L-cells.

Authors:  I Trounce; D C Wallace
Journal:  Somat Cell Mol Genet       Date:  1996-01

2.  Random genetic drift in the female germline explains the rapid segregation of mammalian mitochondrial DNA.

Authors:  J P Jenuth; A C Peterson; K Fu; E A Shoubridge
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

3.  Mitochondrial genotype segregation during preimplantation development in mouse heteroplasmic embryos.

Authors:  F V Meirelles; L C Smith
Journal:  Genetics       Date:  1998-02       Impact factor: 4.562

4.  Mitochondrial genotype segregation in a mouse heteroplasmic lineage produced by embryonic karyoplast transplantation.

Authors:  F V Meirelles; L C Smith
Journal:  Genetics       Date:  1997-02       Impact factor: 4.562

5.  Rhodamine 6G. A potent inhibitor of mitochondrial oxidative phosphorylation.

Authors:  A R Gear
Journal:  J Biol Chem       Date:  1974-06-10       Impact factor: 5.157

6.  Cytoplasmic inheritance of chloramphenicol resistance in mouse tissue culture cells.

Authors:  C L Bunn; D C Wallace; J M Eisenstadt
Journal:  Proc Natl Acad Sci U S A       Date:  1974-05       Impact factor: 11.205

7.  Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice.

Authors:  J P Jenuth; A C Peterson; E A Shoubridge
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

8.  Teratocarcinoma cells as vehicles for introducing specific mutant mitochondrial genes into mice.

Authors:  T Watanabe; M J Dewey; B Mintz
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

9.  Mitochondria transfer into mouse ova by microinjection.

Authors:  C A Pinkert; M H Irwin; L W Johnson; R J Moffatt
Journal:  Transgenic Res       Date:  1997-11       Impact factor: 2.788

10.  Cytoplasmic transfer of chloramphenicol resistance in human tissue culture cells.

Authors:  D C Wallace; C L Bunn; J M Eisenstadt
Journal:  J Cell Biol       Date:  1975-10       Impact factor: 10.539

View more
  14 in total

1.  Transmitochondrial mice: proof of principle and promises.

Authors:  M Hirano
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-16       Impact factor: 11.205

Review 2.  Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.

Authors:  Alessandra Torraco; Susana Peralta; Luisa Iommarini; Francisca Diaz
Journal:  Mitochondrion       Date:  2015-02-04       Impact factor: 4.160

3.  A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations.

Authors:  Weiwei Fan; Katrina G Waymire; Navneet Narula; Peng Li; Christophe Rocher; Pinar E Coskun; Mani A Vannan; Jagat Narula; Grant R Macgregor; Douglas C Wallace
Journal:  Science       Date:  2008-02-15       Impact factor: 47.728

4.  The second genome: Effects of the mitochondrial genome on cancer progression.

Authors:  Adam D Scheid; Thomas C Beadnell; Danny R Welch
Journal:  Adv Cancer Res       Date:  2019-02-27       Impact factor: 6.242

5.  Maternal germ-line transmission of mutant mtDNAs from embryonic stem cell-derived chimeric mice.

Authors:  J E Sligh; S E Levy; K G Waymire; P Allard; D L Dillehay; S Nusinowitz; J R Heckenlively; G R MacGregor; D C Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

Review 6.  Animal models of human mitochondrial DNA mutations.

Authors:  David A Dunn; Matthew V Cannon; Michael H Irwin; Carl A Pinkert
Journal:  Biochim Biophys Acta       Date:  2011-08-11

Review 7.  Nutritional Interventions for Mitochondrial OXPHOS Deficiencies: Mechanisms and Model Systems.

Authors:  Adam J Kuszak; Michael Graham Espey; Marni J Falk; Marissa A Holmbeck; Giovanni Manfredi; Gerald S Shadel; Hilary J Vernon; Zarazuela Zolkipli-Cunningham
Journal:  Annu Rev Pathol       Date:  2017-11-03       Impact factor: 23.472

Review 8.  Mouse models of oxidative phosphorylation defects: powerful tools to study the pathobiology of mitochondrial diseases.

Authors:  Alessandra Torraco; Francisca Diaz; Uma D Vempati; Carlos T Moraes
Journal:  Biochim Biophys Acta       Date:  2008-06-13

9.  Development and initial characterization of xenomitochondrial mice.

Authors:  I A Trounce; M McKenzie; C A Cassar; C A Ingraham; C A Lerner; D A Dunn; C L Donegan; K Takeda; W K Pogozelski; R L Howell; C A Pinkert
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

10.  Production of homoplasmic xenomitochondrial mice.

Authors:  Matthew McKenzie; Ian A Trounce; Carolyn A Cassar; Carl A Pinkert
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.